Table A1 Open in new tab Occurrence of...

Table A1

Occurrence of primary and secondary outcomes

Death during follow-up	Cause of death	Hospitalization for heart failure	Treatment	Frequency	Percent	Cumulative frequency	Cumulative percent
No		No	Tafamidis	57	50.44	57	50.44
		No	No tafamidis	10	8.85	67	59.29
		Yes	Tafamidis	12	10.62	79	69.91
		Yes	No tafamidis	0	0	79	69.91
Yes	Unknown	Unknown	Tafamidis	1	0.88	80	70.79
	Cardiac	No	Tafamidis	1	0.88	81	71.67
		No	No tafamidis	6	5.31	87	76.98
		Yes	Tafamidis	10	8.85	97	85.83
		Yes	No tafamidis	9	7.97	106	93.81
	Non-cardiac	No	Tafamidis	2	1.77	108	95.58
		No	No tafamidis	1	0.88	109	96.46
		Yes	Tafamidis	3	2.65	112	99.11
			No tafamidis	1	0.88	113	100.00

Death during follow-up	Cause of death	Hospitalization for heart failure	Treatment	Frequency	Percent	Cumulative frequency	Cumulative percent
No		No	Tafamidis	57	50.44	57	50.44
		No	No tafamidis	10	8.85	67	59.29
		Yes	Tafamidis	12	10.62	79	69.91
		Yes	No tafamidis	0	0	79	69.91
Yes	Unknown	Unknown	Tafamidis	1	0.88	80	70.79
	Cardiac	No	Tafamidis	1	0.88	81	71.67
		No	No tafamidis	6	5.31	87	76.98
		Yes	Tafamidis	10	8.85	97	85.83
		Yes	No tafamidis	9	7.97	106	93.81
	Non-cardiac	No	Tafamidis	2	1.77	108	95.58
		No	No tafamidis	1	0.88	109	96.46
		Yes	Tafamidis	3	2.65	112	99.11
			No tafamidis	1	0.88	113	100.00